C. Luong

发表

Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2

J. Chow, C. Luong, Aaron Miller, 1996, Nature Structural Biology.

Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases.

J. R. Somoza, D. McRee, Biching Sang, 2004, Structure.

The structure of the extracellular region of human hepsin reveals a serine protease domain and a novel scavenger receptor cysteine-rich (SRCR) domain.

J. R. Somoza, M. Mcgrath, B. Katz, 2003, Structure.

Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targets.

J. Janc, B. Katz, R. Mackman, 2002, Chemistry & biology.

2-(2-Hydroxy-3-alkoxyphenyl)-1H-benzimidazole-5-carboxamidine derivatives as potent and selective urokinase-type plasminogen activator inhibitors.

B. Katz, R. Mackman, C. Luong, 2002, Bioorganic & medicinal chemistry letters.

4-Aminoarylguanidine and 4-aminobenzamidine derivatives as potent and selective urokinase-type plasminogen activator inhibitors.

B. Katz, R. Mackman, C. Luong, 2002, Bioorganic & medicinal chemistry letters.

Structural basis for selectivity of a small molecule, S1-binding, submicromolar inhibitor of urokinase-type plasminogen activator.

B. Katz, R. Mackman, C. Luong, 2000, Chemistry & biology.

Exploiting subsite S1 of trypsin-like serine proteases for selectivity: potent and selective inhibitors of urokinase-type plasminogen activator.

Erik Verner, Liang Liu, B. Katz, 2001, Journal of medicinal chemistry.

Development of serine protease inhibitors displaying a multicentered short (<2.3 A) hydrogen bond binding mode: inhibitors of urokinase-type plasminogen activator and factor Xa.

B. Katz, R. Mackman, C. Luong, 2001, Journal of medicinal chemistry.

Maize Photosystem I : Identification of the Subunit which Binds Plastocyanin.

C. Luong, R. Wynn, R. Malkin, 1989, Plant physiology.

Development of potent and selective factor Xa inhibitors.

W D Shrader, B. Katz, C. Luong, 2001, Bioorganic & medicinal chemistry letters.

Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors.

J. Janc, B. Katz, R. Mackman, 2003, Journal of molecular biology.

A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.

J. Janc, S. Sideris, B. Katz, 2002, Journal of molecular biology.

Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors

H. V. Van Wart, C. Broka, C. Luong, 1999, Nature Structural Biology.

Purification of glycogen phosphorylase isozymes by metal-affinity chromatography.

R. Fletterick, C. Luong, M. Browner, 1992, Journal of chromatography.

Design of potent selective zinc-mediated serine protease inhibitors

Robert M. Stroud, Michael J. Ross, R. Stroud, 1998, Nature.

Designof potent selective zinc-mediatedserine protease inhibitors

R. Stroud, J. Finer-Moore, Charles R. Johnson, 2022 .

Dissecting and designing inhibitor selectivity determinants at the S1 site using an artificial Ala190 protease (Ala190 uPA).

Erik Verner, James W Janc, J. R. Somoza, 2004, Journal of Molecular Biology.

Designofpotentselective zinc-mediatedserine proteaseinhibitors

R. Stroud, J. Finer-Moore, Charles R. Johnson, 1998 .

A RESETTABLE HIGH-DENSITY MICROFLUIDIC CELL TRAPPING SYSTEM

Luke P. Lee, Liwei Lin, Song Li, 2010 .

Partial activation of muscle phosphorylase by replacement of serine 14 with acidic residues at the site of regulatory phosphorylation.

R. Fletterick, C. Luong, M. Browner, 1997, Biochemistry.

Contribution of multicentered short hydrogen bond arrays to potency of active site-directed serine protease inhibitors.

J. Janc, B. Katz, R. Mackman, 2002, Journal of the American Chemical Society.

Recruiting Zn2+ to mediate potent, specific inhibition of serine proteases.

B. Katz, C. Luong, 2000, Journal of molecular biology.